Effects of Exopolysaccharides from Lactiplantibacillus plantarum JLAU103 on Intestinal Immune Response, Oxidative Stress, and Microbial Communities in Cyclophosphamide-Induced Immunosuppressed Mice.
- 2022-02-04
- Journal of Agricultural and Food Chemistry 70(7)
- Ji Wang
- Meihe Li
- Yawen Gao
- Hongmei Li
- Li Fang
- Chunlei Liu
- Xiaoting Liu
- Weihong Min
- PubMed: 35118857
- DOI: 10.1021/acs.jafc.1c06502
Study Design
- Type
- Clinical Trial
- Population
- Immunosuppressed mice
- Methods
- In vivo experiment with immune-suppressed mice.
- Animal Study
Abstract
This study investigated the effects of the exopolysaccharide from Lactiplantibacillus plantarum JLAU103 (EPS103) on the intestinal immune response, oxidative stress, intestinal mucosal barrier, and microbial community in cyclophosphamide-induced immune-suppressed mice. The results showed that EPS103 promoted the secretion of cytokines and the generation of secretory immunoglobulin A and mucin-2 in the small intestine of mice, which might be related to the activation of the MAPK pathway. Additionally, EPS103 protected against oxidative stress by activating antioxidation enzymes and Nrf2/Keap1 pathways. It also improved the intestinal physical barrier functions via regulating the ratio of villous height to crypt depth and upregulating the expression of tight-junction proteins. Meanwhile, EPS103 promoted the generation of short-chain fatty acids (SCFAs) and modulated the constituents of gut microbiota. These results suggested that EPS103 may modulate the intestinal immunoresponse relying on the regulation of SCFA production and gut microbiota in immunosuppressed mice, resulting in the activation of systemic immunity.
Keywords: Lactiplantibacillus plantarum; cyclophosphamide; exopolysaccharide; gut microbiota; immune response.
Research Insights
EPS103 improved the intestinal physical barrier functions via regulating the ratio of villous height to crypt depth and upregulating the expression of tight-junction proteins.
- Effect
- Beneficial
- Effect size
- Large
These results suggested that EPS103 may modulate the intestinal immunoresponse relying on the regulation of SCFA production and gut microbiota in immunosuppressed mice, resulting in the activation of systemic immunity.
- Effect
- Beneficial
- Effect size
- Large
EPS103 promoted the secretion of cytokines and the generation of secretory immunoglobulin A and mucin-2 in the small intestine of mice.
- Effect
- Beneficial
- Effect size
- Moderate
EPS103 promoted the generation of short-chain fatty acids (SCFAs) and modulated the constituents of gut microbiota.
- Effect
- Beneficial
- Effect size
- Moderate